PCR is the enzymatic amplification of a specific DNA fragment targeted by two oligonucleotide primers. It is a surprisingly simple concept but a technology that has become increasingly powerful and broadly implemented. Starting with a DNA or RNA template, repeated cycles of denaturation, primer annealing, and polymerasemediated primer extension generate an exponential accumulation of a specific targeted fragment that can be analyzed by a variety of methods. In addition, PCR is a widely popular and advanced technology used in modern laboratories, which was developed in 1983 by Kary Mullis. Nowadays, PCR is a common and often an indispensable technique, which is used in medical and biological research laboratories for a variety of applications. The technique also allows to perform complex DNA sequencing, electrophoresis or even making custom DNA chains by directly cloning the DNA strands into plasmids.

The report provides market dynamics and trends related to the bioprocess validation market. In addition, it presents estimations and forecast of the market. Bioprocess validation involves a series of activities taking place over the entire production cycle of a bio-product. An important part of bioprocess validation requires the evaluation of active pharmaceutical ingredients (APIs) and possible contaminants such as mycoplasma, bacteria, endotoxin, and others during the development and manufacture processes of human and animal drugs, or other biological products.